| Application no. and date | 04781753.1 (espacenet) (Federated) (European Patent Register), 20040820 | | Patent/reg. no. and date | DK/EP 1663206, 20070404 | | Publication date | 20060607 | | Priority no. and date | US 502562 P, 20030912, US 891953, 20040715 | | EP pub. no. and date |
EP 1663206 20060607 | | Effective date | | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine,
California 92612, US | | Applicant ref. no. | P80701446DK00E | | Inventor | GIL, Daniel, W., 2541 Point Del Mar
Corona Del Mar, CA 92625, US,
DONELLO, John, E., 34041 Pequito Drive
Dana Point, CA 92629, US,
CHOW, Ken, 20 Tidal Surf
Newport Coast, CA 92657, US,
HEIDELBAUGH, Todd, M., 18886 Mt. Castile Circle
Fountain Valley, CA 92708, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4174 (2006.01) , A61P 1/00 (2006.01) , A61P 9/00 (2006.01) , C07D 233/84 (2006.01) | | Title | 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imizadol-2-thion som ikke-sedativ alpha 2A-agonist | | Int. application no. | US2004027134 | | Int. publication no. | WO2005034946 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
